1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Demineralized Bone Matrix and Demineralized Allograft Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Demineralized Bone Matrix and Demineralized Allograft by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Demineralized Bone Matrix and Demineralized Allograft by Country/Region, 2018, 2022 & 2029
2.2 Demineralized Bone Matrix and Demineralized Allograft Segment by Type
2.2.1 Gel
2.2.2 Putty
2.2.3 Putty with Chips
2.2.4 Others
2.3 Demineralized Bone Matrix and Demineralized Allograft Sales by Type
2.3.1 Global Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Type (2018-2023)
2.3.2 Global Demineralized Bone Matrix and Demineralized Allograft Revenue and Market Share by Type (2018-2023)
2.3.3 Global Demineralized Bone Matrix and Demineralized Allograft Sale Price by Type (2018-2023)
2.4 Demineralized Bone Matrix and Demineralized Allograft Segment by Application
2.4.1 Dental Surgery
2.4.2 Spine Surgery
2.4.3 Trauma Surgery
2.5 Demineralized Bone Matrix and Demineralized Allograft Sales by Application
2.5.1 Global Demineralized Bone Matrix and Demineralized Allograft Sale Market Share by Application (2018-2023)
2.5.2 Global Demineralized Bone Matrix and Demineralized Allograft Revenue and Market Share by Application (2018-2023)
2.5.3 Global Demineralized Bone Matrix and Demineralized Allograft Sale Price by Application (2018-2023)
3 Global Demineralized Bone Matrix and Demineralized Allograft by Company
3.1 Global Demineralized Bone Matrix and Demineralized Allograft Breakdown Data by Company
3.1.1 Global Demineralized Bone Matrix and Demineralized Allograft Annual Sales by Company (2018-2023)
3.1.2 Global Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Company (2018-2023)
3.2 Global Demineralized Bone Matrix and Demineralized Allograft Annual Revenue by Company (2018-2023)
3.2.1 Global Demineralized Bone Matrix and Demineralized Allograft Revenue by Company (2018-2023)
3.2.2 Global Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Company (2018-2023)
3.3 Global Demineralized Bone Matrix and Demineralized Allograft Sale Price by Company
3.4 Key Manufacturers Demineralized Bone Matrix and Demineralized Allograft Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Demineralized Bone Matrix and Demineralized Allograft Product Location Distribution
3.4.2 Players Demineralized Bone Matrix and Demineralized Allograft Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Demineralized Bone Matrix and Demineralized Allograft by Geographic Region
4.1 World Historic Demineralized Bone Matrix and Demineralized Allograft Market Size by Geographic Region (2018-2023)
4.1.1 Global Demineralized Bone Matrix and Demineralized Allograft Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Demineralized Bone Matrix and Demineralized Allograft Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Demineralized Bone Matrix and Demineralized Allograft Market Size by Country/Region (2018-2023)
4.2.1 Global Demineralized Bone Matrix and Demineralized Allograft Annual Sales by Country/Region (2018-2023)
4.2.2 Global Demineralized Bone Matrix and Demineralized Allograft Annual Revenue by Country/Region (2018-2023)
4.3 Americas Demineralized Bone Matrix and Demineralized Allograft Sales Growth
4.4 APAC Demineralized Bone Matrix and Demineralized Allograft Sales Growth
4.5 Europe Demineralized Bone Matrix and Demineralized Allograft Sales Growth
4.6 Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales Growth
5 Americas
5.1 Americas Demineralized Bone Matrix and Demineralized Allograft Sales by Country
5.1.1 Americas Demineralized Bone Matrix and Demineralized Allograft Sales by Country (2018-2023)
5.1.2 Americas Demineralized Bone Matrix and Demineralized Allograft Revenue by Country (2018-2023)
5.2 Americas Demineralized Bone Matrix and Demineralized Allograft Sales by Type
5.3 Americas Demineralized Bone Matrix and Demineralized Allograft Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Demineralized Bone Matrix and Demineralized Allograft Sales by Region
6.1.1 APAC Demineralized Bone Matrix and Demineralized Allograft Sales by Region (2018-2023)
6.1.2 APAC Demineralized Bone Matrix and Demineralized Allograft Revenue by Region (2018-2023)
6.2 APAC Demineralized Bone Matrix and Demineralized Allograft Sales by Type
6.3 APAC Demineralized Bone Matrix and Demineralized Allograft Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Demineralized Bone Matrix and Demineralized Allograft by Country
7.1.1 Europe Demineralized Bone Matrix and Demineralized Allograft Sales by Country (2018-2023)
7.1.2 Europe Demineralized Bone Matrix and Demineralized Allograft Revenue by Country (2018-2023)
7.2 Europe Demineralized Bone Matrix and Demineralized Allograft Sales by Type
7.3 Europe Demineralized Bone Matrix and Demineralized Allograft Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft by Country
8.1.1 Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales by Country (2018-2023)
8.1.2 Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Revenue by Country (2018-2023)
8.2 Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales by Type
8.3 Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Demineralized Bone Matrix and Demineralized Allograft
10.3 Manufacturing Process Analysis of Demineralized Bone Matrix and Demineralized Allograft
10.4 Industry Chain Structure of Demineralized Bone Matrix and Demineralized Allograft
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Demineralized Bone Matrix and Demineralized Allograft Distributors
11.3 Demineralized Bone Matrix and Demineralized Allograft Customer
12 World Forecast Review for Demineralized Bone Matrix and Demineralized Allograft by Geographic Region
12.1 Global Demineralized Bone Matrix and Demineralized Allograft Market Size Forecast by Region
12.1.1 Global Demineralized Bone Matrix and Demineralized Allograft Forecast by Region (2024-2029)
12.1.2 Global Demineralized Bone Matrix and Demineralized Allograft Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Demineralized Bone Matrix and Demineralized Allograft Forecast by Type
12.7 Global Demineralized Bone Matrix and Demineralized Allograft Forecast by Application
13 Key Players Analysis
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
13.1.3 Medtronic Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 J &J (DePuy Synthes)
13.2.1 J &J (DePuy Synthes) Company Information
13.2.2 J &J (DePuy Synthes) Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
13.2.3 J &J (DePuy Synthes) Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 J &J (DePuy Synthes) Main Business Overview
13.2.5 J &J (DePuy Synthes) Latest Developments
13.3 SeaSpine
13.3.1 SeaSpine Company Information
13.3.2 SeaSpine Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
13.3.3 SeaSpine Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 SeaSpine Main Business Overview
13.3.5 SeaSpine Latest Developments
13.4 Xtant Medical
13.4.1 Xtant Medical Company Information
13.4.2 Xtant Medical Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
13.4.3 Xtant Medical Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Xtant Medical Main Business Overview
13.4.5 Xtant Medical Latest Developments
13.5 Zimmer Biomet
13.5.1 Zimmer Biomet Company Information
13.5.2 Zimmer Biomet Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
13.5.3 Zimmer Biomet Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Zimmer Biomet Main Business Overview
13.5.5 Zimmer Biomet Latest Developments
13.6 Stryker
13.6.1 Stryker Company Information
13.6.2 Stryker Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
13.6.3 Stryker Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Stryker Main Business Overview
13.6.5 Stryker Latest Developments
13.7 Straumann
13.7.1 Straumann Company Information
13.7.2 Straumann Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
13.7.3 Straumann Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Straumann Main Business Overview
13.7.5 Straumann Latest Developments
13.8 Wright Medical Group
13.8.1 Wright Medical Group Company Information
13.8.2 Wright Medical Group Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
13.8.3 Wright Medical Group Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Wright Medical Group Main Business Overview
13.8.5 Wright Medical Group Latest Developments
13.9 Hans Biomed
13.9.1 Hans Biomed Company Information
13.9.2 Hans Biomed Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
13.9.3 Hans Biomed Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Hans Biomed Main Business Overview
13.9.5 Hans Biomed Latest Developments
13.10 Arthrex
13.10.1 Arthrex Company Information
13.10.2 Arthrex Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
13.10.3 Arthrex Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Arthrex Main Business Overview
13.10.5 Arthrex Latest Developments
14 Research Findings and Conclusion
※参考情報 脱灰骨基質(Demineralized Bone Matrix, DBM)および脱灰同種移植片(Demineralized Allograft)は、骨再生や修復において重要な材料として広く使用されています。これらは、主に骨の治療や再生を必要とするさまざまな医学的状況において、骨の構造や機能を回復させるために用いられます。以下に、これらの概念について詳しく説明します。 まず、脱灰骨基質とは、主に骨組織からミネラル成分を取り除いた基質のことを指します。骨は通常、コラーゲン繊維とミネラル(主にハイドロキシアパタイト)から構成されていますが、脱灰過程を経ることでこのミネラル成分が除去され、主要な有機成分であるコラーゲンが残ります。このプロセスによって、骨の天然の基質特性が維持されつつ、細胞移行や新しい骨組織の形成を促進するための足場となります。脱灰骨基質は、主に成長因子や細胞の接着因子を豊富に含んでおり、これが骨の再生に重要な役割を果たします。 脱灰同種移植片は、他の個体から採取された骨が脱灰処理されたものです。この移植片も、骨の再生や修復に使用されるもので、特に自家骨移植が困難な場合に代替手段として用いられます。脱灰同種移植片は、免疫反応を最小化するために適切な処理が行われ、再生医療において非常に重要な材料として位置づけられています。 これらの脱灰材の特徴として、まず骨再生を促進するために最適な環境を提供する点が挙げられます。脱灰によってミネラルが除去されることで、細胞がこの基質に付着しやすくなり、新たな骨の形成が促進されます。また、脱灰骨基質は、生体適合性が高く、さまざまな外科的手法で使用することができます。加えて、成長因子やサイトカインといった生理活性物質が豊富に含まれており、これらは骨の創傷治癒を早める効果があります。 さらに、多くの研究が行われており、脱灰骨基質はさまざまな形態や製品として利用されています。例えば、スパンクリスタル(粒状)やマトリックス(シート状)など、用途によって異なる形態が存在します。また、これらの製品は骨の移植や修復に使用されるだけでなく、歯科、整形外科、外科などの分野でも広く利用されています。 用途に関しては、脱灰骨基質および脱灰同種移植片は、骨折や骨欠損、骨形成不全に対する治療に用いられることが一般的です。特に、骨の形成が期待される部位や再生が困難な部位に対して非常に効果的です。さらに、これらは地域の局所麻酔下で簡単に使用できることから、外科的介入の際にも有用です。 関連技術としては、再生医療分野における幹細胞技術や成長因子の利用があります。最近の研究では、脱灰骨基質に幹細胞を組み合わせることで、さらに高い再生促進効果が期待されています。このような技術の進展は、今後の治療法の進化にも寄与することが期待されます。 最後に、脱灰骨基質および脱灰同種移植片の使用における倫理的な配慮や規制についても注意が必要です。すべての医療材料において安全性が重要視される中、これらの製品は適切な法的手続きを経て製造され、使用されなければなりません。 脱灰骨基質と脱灰同種移植片は、現代の医療において重要な役割を果たしています。これらの材料の特性を理解し、適切な用途に活用することが、今後の医学の進展に寄与することでしょう。患者の治療における選択肢を広げ、より良いアウトカムを目指すために、これらの技術はますます重要となるでしょう。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/